Drugplain

Namzaric 10 mg/1

memantine hydrochloride and donepezil hydrochloride · CAPSULE · Allergan, Inc.

No Recall HistoryCurrently in Shortage
Plain English

Namzaric is a capsule containing memantine hydrochloride and donepezil hydrochloride at 10 mg/1, taken oral. Manufactured by Allergan, Inc..

Key Facts

Brand Name
Namzaric
Generic Name
memantine hydrochloride and donepezil hydrochloride
NDC Code (Product)
0456-1221
Manufacturer
Allergan, Inc.
Strength
10 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
NDA206439
Marketing Start
07/18/2016

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

dizziness58 reports
death56 reports
confusional state48 reports
drug ineffective42 reports
fall42 reports
hallucination38 reports
fatigue37 reports
diarrhoea36 reports
nausea33 reports
vomiting32 reports

Frequently Asked Questions

What is Namzaric used for?

Namzaric contains memantine hydrochloride and donepezil hydrochloride. It is a capsule taken oral. Consult your doctor for specific uses.

Is Namzaric a controlled substance?

Namzaric is not classified as a controlled substance by the DEA.

What is the generic name for Namzaric?

The generic name for Namzaric is memantine hydrochloride and donepezil hydrochloride. There are 2 other brand versions of memantine hydrochloride and donepezil hydrochloride.

What is the NDC code for Namzaric 10 mg/1?

The NDC (National Drug Code) for Namzaric 10 mg/1 is 0456-1221, listed by Allergan, Inc..

Product NDC

0456-1221

Package NDC

0456-1221-30

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)